2.60
-0.12 (-4.41%)
-0.12 (-4.41%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sesen Bio Inc | SESN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.12 | -4.41% | 2.60 | 19:57:40 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.73 | 2.56 | 2.75 | 2.56 | 2.72 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.57 | 2.60 | 0.03 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,422 | 5,401,765 | $ 2.66 | $ 14,360,486 | 4,322,190 | 0.37 - 3.54 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:37 | formt | 100 | $ 2.60 | USD |
Sesen Bio Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 336.28M | 129.34M | 129.27M | $ - | $ - | -1.21 | -3.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Sesen Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SESN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.825 | 2.97 | 2.44 | 2.73 | 6,323,715 | -0.225 | -7.96% |
| 1 Month | 1.80 | 3.54 | 1.73 | 2.83 | 10,479,337 | 0.80 | 44.44% |
| 3 Months | 1.54 | 3.54 | 1.15 | 2.26 | 6,719,658 | 1.06 | 68.83% |
| 6 Months | 1.01 | 3.54 | 0.91 | 1.96 | 4,331,296 | 1.59 | 157.43% |
| 1 Year | 0.78 | 3.54 | 0.37 | 1.70 | 2,715,568 | 1.82 | 233.33% |
| 3 Years | 0.90 | 3.54 | 0.37 | 1.69 | 2,239,219 | 1.70 | 188.89% |
| 5 Years | 0.306 | 5.97 | 0.283 | 1.78 | 1,864,335 | 2.29 | 749.67% |
Sesen Bio Description
| Sesen Bio Inc is a late-stage clinical company engaged in next-generation antibody-drug conjugate therapies for the treatment of cancer-based on the company's Targeted Protein Therapeutics platform. The company's lead program, Vicinium, also known as VB4-845, is currently in a Phase 3 registration trial, the VISTA Trial, for the treatment of high-grade non-muscle invasive bladder cancer. |
